Saudi Nod Positions OneSource for Growth in GLP-1 Therapies
OneSource Specialty Pharma Limited has secured approval from the Saudi Food and Drug Authority (SFDA) for its generic version of Ozempic (semaglutide), enabling the company to begin commercialisation in Saudi Arabia through an exclusive partnership with Hikma Pharmaceuticals.
Engineering | 11/02/2026 | By Darshana | 478
New Invivoscribe Platform Targets KMT2A Rearrangements in AML Trials
Invivoscribe, a precision diagnostics company focused on measurable residual disease (MRD) testing, has expanded its oncology portfolio with the launch of the LeukoStrat KMT2A + MRD Assay and Software.
Engineering | 06/02/2026 | By Darshana | 181
India's 2026 Budget Sets Stage for Biopharmaceutical Manufacturing Boom: OPPI
The Organisation of Pharmaceutical Producers of India (OPPI) has described the Union Budget 2026 as a pivotal moment in India’s journey to becoming a global biopharmaceutical manufacturing leader.
Engineering | 02/02/2026 | By Darshana | 239
Eli Lilly Enters USD 1.12 Billion Gene-Editing Partnership with Seamless Therapeutics
Eli Lilly and Company has entered into a strategic collaboration worth up to USD 1.12 billion with private gene-editing company Seamless Therapeutics to develop next-generation therapies for hearing loss. The agreement strengthens Lilly’s push into genetic medicines and expands its pipeline beyond its core diabetes and obesity treatments.
Engineering | 29/01/2026 | By Darshana | 233
India - EU FTA Must Ensure Level Playing Field for Medical Device Makers: AiMeD
The proposed India–European Union Free Trade Agreement (FTA) has the potential to reshape India’s pharmaceutical and medical devices landscape, but industry leaders caution that its success will depend on how fairly it balances market access, regulatory alignment and domestic manufacturing interests.
Engineering | 28/01/2026 | By Darshana | 284
Alphatec Signs Strategic US Commercial Deal with Theradaptive, Backs Series B Expansion
Alphatec Holdings Inc (ATEC), a spine-focused medical technology company, and Theradaptive Inc, a clinical-stage regenerative medicine innovator, have entered into a definitive strategic partnership to advance next-generation biologic solutions for spine surgery.
Engineering | 14/01/2026 | By Darshana | 2333
Bayer Partners with Souffle Therapeutics to Develop Heart-Targeted siRNA Therapy
Bayer and Soufflé Therapeutics, a biotechnology company focused on developing cell-selective genetic medicines, have entered into a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy for a rare form of dilated cardiomyopathy.
Engineering | 09/01/2026 | By Darshana | 768
Agilent Advances Sustainable Science with New India Refurbishment Centre
Agilent Technologies has inaugurated a new refurbishment centre in India, reinforcing its commitment to sustainable science and affordable innovation while enhancing customer engagement through an integrated, green-certified facility that also houses a dedicated education centre.
Engineering | 18/12/2025 | By News Bureau | 323
AlidaBio Launches EpiPlex Duo-Mod for Dual m6A-Inosine Mapping with RNA Expression Profiling
AlidaBio has launched the EpiPlex Duo-Mod Service, offering simultaneous m6A and inosine mapping with integrated gene expression profiling, enabling researchers to compare modification patterns and transcriptional changes from a single RNA input.
Engineering | 06/12/2025 | By Dineshwori | 229
Continuous Tableting Breakthrough: GEA and Hovione Introduce ConsiGma CDC Flex System
GEA and Hovione have expanded their long-standing partnership with the launch of the ConsiGma CDC Flex system — a next-generation continuous direct compression (CDC) platform designed to deliver greater flexibility, simplicity and cost-efficiency in the development and production of oral solid dosage forms.
Engineering | 04/12/2025 | By Dineshwori | 242
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy